| Fund ID | 805-6018228793 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 1% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 46% |
| Fund | Type | Gross assets |
|---|---|---|
| Titan Masters Fund, L.P. | Hedge | $324.9M |
| Titan Legacy Fund I, L.P. Series B | Hedge | $245.1M |
| Titan Legacy Credit & Distressed LP | Private Equity | $191.6M |
Titan Fund I SPC - Titan Biotech Dislocation Fund Sp reports $38.2 million in gross assets, among the top 59% of private funds by size.
The stated minimum investment is $100,000.
Titan Fund I SPC - Titan Biotech Dislocation Fund Sp is managed by Titan Advisors, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.